Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Studies on some neuropharmacological properties of Nevirapine in mice. Local targets link to admitted publications; unresolved targets remain external evidence.
Medicinal plants with reported anxiolytic and sedative activities in Nigeria: A systematic review
10.26650/istanbuljpharm.2019.18008 · 2019 · External reference
Behavioural effect of Pavetta crassipes extract on rodents
10.1016/j.pbb.2004.01.020 · 2004 · External reference
Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma
10.1086/498310 · 2005 · External reference
Development of nevirapine resistance in children exposed to the prevention of mother-to-child HIV-1 transmission programme in Maputo, Mozambique
10.1371/journal.pone.0131994 · 2015 · External reference
Neuroprotective effect of Nevirapine on cerebral ischemic stroke by middle cerebral artery occlusion in wistar rats
10.21477/ijapsr.v1i1.9604 · 2016 · External reference
Drugs and the treatment of psychiatric disorders; psychosis and anxiety
1996 · External reference
Nevirapine-versus lopinavir/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial
10.1093/cid/ciw488 · 2016 · External reference
Some doubts about the basic concept of hole-board test
1996 · External reference
The effects of poverty on children
10.2307/1602387 · 1997 · External reference
Unresolved reference
External reference
Drugs and dysphagia
10.1044/sasd17.4.143 · 2008 · External reference
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
10.1016/0091-3057(80)90067-2 · 1980 · External reference
Exploratory behavior models of anxiety in mice
10.1016/0149-7634(85)90030-2 · 1985 · External reference
Update on disorders of sleep and the sleep-wake cycle
1992 · External reference
Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid
10.1097/00002030-200009080-00010 · 2000 · External reference
Pharmacological and clinical evidence of nevirapine immediate-and extended-release formulations
2012 · External reference
How much do antiretroviral drugs penetrate into the central nervous system?
2011 · External reference
Unresolved reference
1978 · External reference
Dizocilpine prevents the development of tolerance to the sedative effects of diazepam in rats
10.1016/0091-3057(94)90282-8 · 1994 · External reference
Validity of head-dipping as a measure of exploration in a modified hole-board
10.1007/bf00421184 · 1975 · External reference
Challenging new targets for CNS-HIV infection
10.3389/fneur.2012.00043 · 2012 · External reference
Basic science of sleep
2000 · External reference
Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice
10.1016/j.ejphar.2013.04.003 · 2013 · External reference
GABA mechanisms and sleep
10.1016/s0306-4522(02)00034-9 · 2002 · External reference
Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments
2001 · External reference
Deaths: Leading causes for 2017
2019 · External reference
Studies on the anticonvulsive, sedative and hypothermic effects of Periostracum Cicadae extracts
10.1016/0378-8741(91)90136-2 · 1991 · External reference
Cutaneous adverse drug reactions from a teaching hospital in Bengaluru: An observational study to determine the spectrum and outcome
2017 · External reference
Efficacy of phone use on adherence to nevirapine prophylaxis and retention in care among HIV-exposed infants in prevention of mother to child transmission of HIV: a randomized clinical trial
2014 · External reference
Neurologic complications of HIV disease and their treatment
2010 · External reference
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders
10.1002/ana.20198 · 2004 · External reference
A new approach to practical acute toxicity testing
10.1007/bf01234480 · 1983 · External reference
Drugs effective in the therapy of the epilepsies
1996 · External reference
Clinically significant interactions of psychotropic agents with antipsychotic drugs
10.2165/00002018-199615050-00004 · 1996 · External reference
Central depressant effects of reticuline extracted from Ocotea duckei in rats and mice
10.1016/s0378-8741(98)00044-0 · 1998 · External reference
Strategies to advance translational research into brain barriers
10.1016/s1474-4422(07)70326-5 · 2008 · External reference
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals
2016 · External reference
Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds
10.1016/j.pnpbp.2007.07.023 · 2008 · External reference
Behavioral effects of 6-bromoflavanone and 5-methoxy-6, 8-dibromoflavanone as anxiolytic compounds
10.1016/j.pnpbp.2007.07.023 · 2008 · External reference
Unresolved reference
2019 · External reference
Antagonism of pentobarbitone sleep by dopamine, levodopa and apomorphine in chicks
10.1111/j.1440-1681.1980.tb00068.x · 1980 · External reference
Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous system in mice
10.1016/s0944-7113(96)80027-4 · 1996 · External reference
Blood-brain barrier delivery
10.1016/j.drudis.2006.10.013 · 2007 · External reference
Nevirapine
10.1007/bf03259093 · 1996 · External reference
Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
10.1016/0165-0270(85)90031-7 · 1985 · External reference
Targeting anti-HIV drugs to the CNS
10.1517/17425240903081705 · 2009 · External reference
Opioid analgesics and antagonists
1996 · External reference
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study
10.1212/wnl.0000000000002277 · 2016 · External reference
Sedative-hypnotic like effect of 5-methoxyflavone in mice and investigation on possible mechanisms by in vivo and in silico methods
10.1016/j.biopha.2018.08.117 · 2018 · External reference
Sedative–hypnotic like effect of 5–methoxyflavone in mice and investigation on possible mechanisms by in vivo and in silico methods
10.1016/j.biopha.2018.08.117 · 2018 · External reference
Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment
10.1128/jvi.78.18.10133-10148.2004 · 2004 · External reference
HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment
10.1101/cshperspect.a007120 · 2012 · External reference
Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice
10.1016/s0014-2999(98)00223-4 · 1998 · External reference
Unresolved reference
External reference
The transport of anti-HIV drugs across blood–CNS interfaces: summary of current knowledge and recommendations for further research
10.1016/j.antiviral.2008.12.013 · 2009 · External reference
Serotonin and sleep-wakefulness
10.1111/j.1749-6632.1990.tb16901.x · 1990 · External reference
Behavioral properties of Balanites aegyptiaca in rodents
10.1016/j.jep.2011.04.003 · 2011 · External reference
Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats
2014 · External reference
